Czech Technical-UPenn-NYU Team Wins Grand Challenge in US$5-Million MBZIRC2020 Organized by Khalifa University
26.2.2020 17:14:00 EET | Business Wire | Press release
H.E. Dr. Mugheer Khamis Al Khaili, Member of the Executive Council, and Chairman of Department of Community Development today honored the Grand Challenge team winners Czech Technical University-University of Pennsylvania-NYU and winners of the three Challenge categories at the three-day US$5-million Mohamed Bin Zayed International Robotics Challenge (MBZIRC) 2020 that concluded in Abu Dhabi, organizers Khalifa University of Science and Technology announced today.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200226005539/en/
Czech Technical-UPenn-NYU Team Wins Grand Challenge in US$5-Million MBZIRC2020 organized by Khalifa University (Photo: AETOSWire)
The winning teams in all three categories – Challenge 1, 2, and 3 – also received awards from H.E. Dr. Mugheer Khamis Al Khaili at the ceremony.
His Excellency Hussein Bin Ibrahim Al Hammadi, Steering Committee General Chair, MBZIRC 2020, Dr. Arif Sultan Al Hammadi, Steering Committee General Co-Chair, and His Excellency Dr. Mohammed Al Mualla, Steering Committee Member, were present.
Others who attended the ceremony included UAE government officials, Challenge partners, stakeholders from the academia, research, and industry, as well as all the MBZIRC 2020 team members.
The Czech Technical University-University of Pennsylvania-NYU team won the first position in the Grand Challenge. The University of Bonn team came second, while the combined team of Universidad Politecnica Madrid-Universidad Pablo Olvide Poznan University of Technology- Centre National de la Recherche Scientifique won the third place.
The Beijing Institute of Technology topped Challenge 1 category with the Czech Technical University-University of Pennsylvania-NYU team and the University of Tokyo in the second and third places, respectively, while the Czech Technical University-University of Pennsylvania-NYU team won the Challenge 2 category with Nimbro (University of Bonn) and Technical University of Denmark in the second and third places. Challenge 3 was won by University of Seville-Tecnico Lisboa-CATEC team, while the Technical University of Denmark and the University of New South Wales-Sydney tied for the second place.
The 32 finalists, representing 17 countries, were shortlisted out of 134 teams from across the globe that applied to compete in MBZIRC 2020.
Dr. Arif Sultan Al Hammadi said: “The second edition of MBZIRC has emphatically placed MBZIRC as one of the most prestigious competitions in robotics and artificial intelligence globally, while positioning Khalifa University as the leading higher education institution driving innovation in all areas of science, engineering, and newly-emerging technologies.”
Dr. Al Hammadi added: “Congratulations to all the winners of MBZIRC 2020, especially the Grand Challenge winner and winners of all three Challenge categories. However, all the participating teams deserve credit for their commitment, determination and perseverance during the competition, consistently raising the bar of excellence as displayed by various autonomous drones. Through this Challenge, we have witnessed how technology continues to evolve and we firmly believe the advancements demonstrated by these UAVs and UGVs will very soon become part of our everyday lives.”
For more information, please visit: http://www.ku.ac.ae/
*Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200226005539/en/
Contact information
APCO Worldwide
Abdullah Al Sayed, Account Director, +971504887044
aalsayed@apcoworldwide.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 21:00:00 EET | Press release
Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasoc
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 21:00:00 EET | Press release
Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). The late-breaking oral presentation of these data is taking place at the 2026 American Academy of Dermatology (AAD) Annual Meeting, being held March 27-31, 2026, in Denver (Session: S034 – Late-Breaking Research: Session 2. Saturday, March 28, 2026, 1:00-4:00 p.m. MT). “The 54-week results from the STOP-HS program deliver compelling, long-term evidence supporting the potential of povorcitinib for patients with moderate to severe HS,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “Across both studies, povorcitinib demonstrated substantial and durable improvements over time in key measures of treatment success and meaningful clinical ben
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 17:00:00 EET | Press release
Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-breaking session at the 2026 American Academy of Dermatology (AAD) Annual Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260328320362/en/ Atopic dermatitis is the most common inflammatory skin disorder in children, yet treatment options in the moderate-to-severe pediatric setting are limited.5 The disease can have a significant impact on quality of life for both the patients and their loved ones, with persistent itch and recurrent skin lesions often disrupting sleep, school and relationships.5-8 “Atopic dermatitis can affect many aspects of children’s lives including schoolwork, emotional development
Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 21:56:00 EET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 19:46:00 EET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom